Compare ADMA Biologics Inc (ADMA) vs SOLAI Limited (SLAI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs SOLAI Limited — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while SOLAI Limited trades at $3.72 (market cap $16.69M). The key difference: ADMA Biologics Inc is far larger — about 133× SOLAI Limited's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, SOLAI Limited nearer its low. Which is the better fit depends on your goals.
| ADMA | SLAI | |
|---|---|---|
Market Cap | $2.22B | $16.69M |
Sector | Health | Technology |
52-Week High | $20.38 | $26.74 |
52-Week Low | $7.60 | $2.74 |
Enterprise Value | $2.29B | $16.33M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About SOLAI Limited
SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.
Read more on SLAI →
